A Publication in the May 2016 issue of TRANSFUSION Addresses Whether Pathogen Reduction (PR) of Blood Components will Harm More People than it helps in Developed Countries
Hess and colleagues assert that hemorrhagic risk from reduced blood product potency of pathogen-reduced (PR) platelets and PR plasma for patients with trauma and other indications for massive transfusion is an important consideration in risk-based decision making for implementing PR.
Read the Article Review
The PGD testing system
The Company's first product is the Platelet PGD Test – a rapid test for the detection of bacterial contamination in platelets.